Skip to content

Efficacy and safety of INTRABEAM system in postoperative radiotherapy for keloids

Efficacy and safety of INTRABEAM system in postoperative radiotherapy for keloids

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018044
Enrollment
Unknown
Registered
2018-08-28
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

keloids

Interventions

1:treat by Intrabeam
2:Electron beam irradiation of conventional accelerator 6MV

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with keloids diagnosed by pathology; 2. The maximum diameter of the scar is less than 5cm; 3. Age 18 to 70 years old; 4. In general, can tolerate radiotherapy; 5. Non-pregnancy and lactation; 6. The subject agrees and signs the informed consent form (if the subject does not have the ability to judge, the legal guardian is required to sign the informed consent form).

Exclusion criteria

Exclusion criteria: 1. Those who have had previous radiotherapy in previous scars; 2. Accompanied by a serious uncontrollable infection or medical disease; 3. Patients with cognitive dysfunction or poor adherence to radiotherapy by the investigator.

Design outcomes

Primary

MeasureTime frame
Skin reaction;

Countries

China

Contacts

Public ContactXiaojing Yang

Shanghai Sixth People's Hospital

yangxj717@163.com+86 13818105740

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026